These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30838094)

  • 21. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
    Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
    AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up.
    Park CM; Goo JM; Lee HJ; Lee CH; Chun EJ; Im JG
    Radiographics; 2007; 27(2):391-408. PubMed ID: 17374860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
    Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HRCT morphological characteristics distinguishing minimally invasive pulmonary adenocarcinoma from invasive pulmonary adenocarcinoma appearing as subsolid nodules with a diameter of ≤3 cm.
    Yue X; Liu S; Liu S; Yang G; Li Z; Wang B; Zhou Q
    Clin Radiol; 2018 Apr; 73(4):411.e7-411.e15. PubMed ID: 29273229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules.
    Cha MJ; Lee KS; Kim HS; Lee SW; Jeong CJ; Kim EY; Lee HY
    Expert Rev Respir Med; 2016; 10(3):261-78. PubMed ID: 26751340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
    Higashi K; Sakuma T; Ito K; Niho S; Ueda Y; Kobayashi T; Sekiguchi R; Takahashi T; Kato T; Tonami H
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):373-81. PubMed ID: 18931837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity.
    Si MJ; Tao XF; Du GY; Cai LL; Han HX; Liang XZ; Zhao JM
    Eur J Radiol; 2016 Oct; 85(10):1708-1715. PubMed ID: 27666606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity.
    Liu Y
    PET Clin; 2018 Jan; 13(1):11-18. PubMed ID: 29157381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma].
    Liu WK; Li XD; Quan JT; Ouyang X; Zheng H
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):114-6. PubMed ID: 25613623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
    Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
    Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
    Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma: comparison with 18F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness.
    Shibata H; Nomori H; Uno K; Iyama K; Tomiyoshi K; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
    Ann Nucl Med; 2009 Sep; 23(7):609-16. PubMed ID: 19562438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the Blood Supply Status of the Focal Ground-Glass Opacity in Lungs Using Spectral Computed Tomography.
    Liu G; Li M; Li G; Li Z; Liu A; Pu R; Cao H; Liu Y
    Korean J Radiol; 2018; 19(1):130-138. PubMed ID: 29354009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan.
    Suzuki K; Asamura H; Kusumoto M; Kondo H; Tsuchiya R
    Ann Thorac Surg; 2002 Nov; 74(5):1635-9. PubMed ID: 12440622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
    Watanabe K; Nomori H; Ohtsuka T; Naruke T; Ebihara A; Orikasa H; Yamazaki K; Uno K; Kobayashi T; Goya T
    Jpn J Clin Oncol; 2006 Jul; 36(7):403-9. PubMed ID: 16782729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons.
    Lee HY; Lee KS; Han J; Kim BT; Cho YS; Shim YM; Kim J
    Lung Cancer; 2009 Aug; 65(2):170-5. PubMed ID: 19111932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.